Ulan Sarymsakov, a clinical specialist from the Republican Center for the Control of Hematogenous Viral Hepatitis and HIV, presented statistics on viral hepatitis in Kyrgyzstan as of January 1, 2026. According to him, screenings began in 2022. During the study, 1,140,946 people were tested for hepatitis B virus, of which 37,946 (3.33%) tested positive. At the same time, 1,137,130 people were screened for hepatitis C virus, and 11,035 (0.97%) of them were found to be positive.
Additionally, according to the specialist's data, from 2024 to 2025, 26,925 people were tested for hepatitis D virus, among which 919 (3.4%) received a positive result.
Currently, 19,325 people are registered for hepatitis B virus, of which 5,439 are undergoing treatment. Regarding hepatitis D virus, 3,363 people are registered, 2,674 of whom are receiving therapy. For hepatitis C virus, 10,862 people are on record, and 6,890 of them are undergoing treatment.
Sarymsakov also highlighted vaccination issues against hepatitis B virus: the first dose of the vaccine was received by 312,447 people, the second dose by 256,144 (which is 82% of those vaccinated with the first dose), and the third dose was received by 191,883 (75% of those who received the second dose).
